News

With the completion of the spin off of the immunotherapy business, including its listeria and KBMA platform technologies, Cerus is now solely focused on commercializing the Intercept Blood

Elevess is the first injectable soft-tissue filler for facial wrinkles, scar remediation and lip augmentation to incorporate lidocaine, a local anesthetic designed to improve patient comfort. Under the

Recent changes in the vaccines sector has resulted in more manufacturers entering into low margin areas, such as flu vaccines, thus creating severe competition. The company said it

The objective of the study is to assess the safety, tolerability and analgesic efficacy of ARRY-797 dosed either after the operation or both before and after surgery. Although

Opioid dependence is a chronic, relapsing medical condition that requires long-term treatment and patient support. A combo therapy was developed based on Naloxone, an opioid receptor antagonist, alongside

The Committee for Medicinal Products for Human Use decision is based on data from a pivotal Phase III trial, which showed that adding Avastin to interferon gave patients

The 12-week Phase II multicenter, double-blind, randomized, active controlled clinical trial enrolled a total of 220 patients with mixed dyslipidemia, across 14 centers in the US. The clinical

The Digibind efficacy evaluation in pre-eclampsia (DEEP) study is a placebo-controlled investigation of the efficacy and safety of GlaxoSmithKline’s Digibind in 50 patients with severe pre-eclampsia. The study

This Phase I/II trial is a four-week, open label study designed to establish the pharmacokinetic profile and safety of CTAP101 capsules in subjects with vitamin D insufficiency. The